HomeCompareWUXIF vs NOBL

WUXIF vs NOBL: Dividend Comparison 2026

WUXIF yields 0.94% · NOBL yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WUXIF wins by $3.66M in total portfolio value· pulled ahead in Year 2
10 years
WUXIF
WUXIF
● Live price
0.94%
Share price
$13.88
Annual div
$0.13
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.68M
Annual income
$3,055,751.48
Full WUXIF calculator →
NOBL
NOBL
● Live price
2.14%
Share price
$106.01
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$246.19
Full NOBL calculator →

Portfolio growth — WUXIF vs NOBL

📍 WUXIF pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWUXIFNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WUXIF + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WUXIF pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WUXIF
Annual income on $10K today (after 15% tax)
$79.61/yr
After 10yr DRIP, annual income (after tax)
$2,597,388.76/yr
NOBL
Annual income on $10K today (after 15% tax)
$182.19/yr
After 10yr DRIP, annual income (after tax)
$209.26/yr
At 15% tax rate, WUXIF beats the other by $2,597,179.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WUXIF + NOBL for your $10,000?

WUXIF: 50%NOBL: 50%
100% NOBL50/50100% WUXIF
Portfolio after 10yr
$1.85M
Annual income
$1,527,998.83/yr
Blended yield
82.48%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WUXIF buys
0
NOBL buys
0
No recent congressional trades found for WUXIF or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWUXIFNOBL
Forward yield0.94%2.14%
Annual dividend / share$0.13$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%0%
Portfolio after 10y$3.68M$22.8K
Annual income after 10y$3,055,751.48$246.19
Total dividends collected$3.61M$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: WUXIF vs NOBL ($10,000, DRIP)

YearWUXIF PortfolioWUXIF Income/yrNOBL PortfolioNOBL Income/yrGap
1$10,887$187.32$10,914$214.34$27.00NOBL
2← crossover$12,031$381.20$11,897$218.63+$134.00WUXIF
3$13,660$787.34$12,952$222.72+$708.00WUXIF
4$16,287$1,671.00$14,086$226.62+$2.2KWUXIF
5$21,152$3,724.08$15,302$230.33+$5.8KWUXIF
6$31,672$9,039.75$16,607$233.85+$15.1KWUXIF
7$59,190$25,300.84$18,007$237.18+$41.2KWUXIF
8$151,713$88,379.99$19,508$240.35+$132.2KWUXIF
9$585,758$423,425.00$21,116$243.35+$564.6KWUXIF
10$3,682,512$3,055,751.48$22,841$246.19+$3.66MWUXIF

WUXIF vs NOBL: Complete Analysis 2026

WUXIFStock

WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.

Full WUXIF Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this WUXIF vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WUXIF vs SCHDWUXIF vs JEPIWUXIF vs OWUXIF vs KOWUXIF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.